West Pharmaceutical Services Stock Fundamentals
| WST Stock | USD 319.79 3.20 1.01% |
West Pharmaceutical Services fundamentals help investors to digest information that contributes to West Pharmaceutical's financial success or failures. It also enables traders to predict the movement of West Stock. The fundamental analysis module provides a way to measure West Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to West Pharmaceutical stock.
At this time, West Pharmaceutical's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 732.9 M in 2024, despite the fact that Non Operating Income Net Other is likely to grow to (27.9 M). West | Select Account or Indicator |
West Pharmaceutical Services Company Shares Outstanding Analysis
West Pharmaceutical's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current West Pharmaceutical Shares Outstanding | 72.42 M |
Most of West Pharmaceutical's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, West Pharmaceutical Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
West Shares Outstanding Historical Pattern
Today, most investors in West Pharmaceutical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various West Pharmaceutical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of West Pharmaceutical shares outstanding as a starting point in their analysis.
West Pharmaceutical Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
West Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, West Pharmaceutical Services has 72.42 M of shares currently outstending. This is 59.88% lower than that of the Health Care Equipment & Supplies sector and 15.69% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 87.33% higher than that of the company.
West Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining West Pharmaceutical's current stock value. Our valuation model uses many indicators to compare West Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across West Pharmaceutical competition to find correlations between indicators driving West Pharmaceutical's intrinsic value. More Info.West Pharmaceutical Services is rated second in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for West Pharmaceutical Services is roughly 1.78 . At this time, West Pharmaceutical's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value West Pharmaceutical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.West Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses West Pharmaceutical's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of West Pharmaceutical could also be used in its relative valuation, which is a method of valuing West Pharmaceutical by comparing valuation metrics of similar companies.West Pharmaceutical is currently under evaluation in shares outstanding category among its peers.
West Pharmaceutical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, West Pharmaceutical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to West Pharmaceutical's managers, analysts, and investors.Environmental | Governance | Social |
West Fundamentals
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 22.74 B | ||||
| Shares Outstanding | 72.42 M | ||||
| Shares Owned By Insiders | 0.58 % | ||||
| Shares Owned By Institutions | 96.69 % | ||||
| Number Of Shares Shorted | 1.43 M | ||||
| Price To Earning | 40.71 X | ||||
| Price To Book | 8.33 X | ||||
| Price To Sales | 7.97 X | ||||
| Revenue | 2.95 B | ||||
| Gross Profit | 1.14 B | ||||
| EBITDA | 847.8 M | ||||
| Net Income | 593.4 M | ||||
| Cash And Equivalents | 894.3 M | ||||
| Cash Per Share | 9.85 X | ||||
| Total Debt | 309 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 3.80 X | ||||
| Book Value Per Share | 37.96 X | ||||
| Cash Flow From Operations | 776.5 M | ||||
| Short Ratio | 1.83 X | ||||
| Earnings Per Share | 6.74 X | ||||
| Price To Earnings To Growth | 5.91 X | ||||
| Target Price | 361.57 | ||||
| Number Of Employees | 10.6 K | ||||
| Beta | 1.0 | ||||
| Market Capitalization | 22.93 B | ||||
| Total Asset | 3.83 B | ||||
| Retained Earnings | 3.52 B | ||||
| Working Capital | 1.26 B | ||||
| Current Asset | 673.7 M | ||||
| Current Liabilities | 314.3 M | ||||
| Annual Yield | 0 % | ||||
| Five Year Return | 0.36 % | ||||
| Net Asset | 3.83 B | ||||
| Last Dividend Paid | 0.8 |
About West Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze West Pharmaceutical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of West Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of West Pharmaceutical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 41.7 M | 38.2 M | |
| Total Revenue | 2.9 B | 3.1 B | |
| Cost Of Revenue | 1.8 B | 1.9 B | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.15 | 0.18 | |
| Research And Ddevelopement To Revenue | 0.02 | 0.02 | |
| Capex To Revenue | 0.12 | 0.11 | |
| Revenue Per Share | 39.70 | 41.69 | |
| Ebit Per Revenue | 0.23 | 0.24 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.